Vivos Inc.

RDGL ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2017
Revenue $68.4K $5.0K $19.5K $36.5K $14.9K $7.0K $9.5K $4.1K
Cost of Revenue $128.1K $31.0K $25.5K $28.8K $12.0K $5.6K $6.0K —
Gross Profit $-59.8K $-3.0K $-6.0K $7.7K $2.9K $1.4K $3.5K —
Gross Margin -87.4% -59.7% -31.0% 21.2% 19.4% 19.9% 36.5% —
Operating Expenses
Research & Development $352.2K $324.6K $732.7K $343.8K $286.8K $84.7K $67.6K $203.0K
SG&A Expense $296.6K $241.8K $165.8K $151.1K $112.0K $109.0K $74.3K $109.5K
Operating Income $-3.2M $-2.6M $-2.8M $-2.5M $-2.5M $-672.5K $-1.3M $-2.6M
Operating Margin -4,628.7% -52,139.8% -14,323.8% -6,898.1% -16,805.3% -9,607.4% -13,999.8% -64,551.4%
Interest Expense — — — — $25.4K $287.5K $261.4K $3.9M
Pretax Income $-3.1M $-2.9M $-2.9M $-2.5M $-2.5M $-957.0K $-1.6M $-6.4M
Income Tax Expense — — — — $0 $0 — —
Net Income $-3.1M $-2.9M $-2.9M $-2.5M $-2.5M $-957.0K $-1.6M $-6.4M
Net Margin -4,483.9% -58,267.2% -14,844.9% -6,767.7% -16,979.7% -13,671.3% -16,948.4% -158,330.7%
EPS (Basic) $-0.01 $-0.01 $-0.01 $-0.01 $-0.01 $0.00 $-0.01 $-0.04
EPS (Diluted) $-0.01 $-0.01 $-0.01 $-0.01 $-0.01 $0.00 $-0.01 $-0.04
Shares Outstanding (Basic) 452.7M 409.7M 368.8M 351.4M 325.9M 222.8M 175.2M 197.1M
Shares Outstanding (Diluted) 452.7M 409.7M 368.8M 351.4M 325.9M 222.8M 175.2M 197.1M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 2 Older →